Search This Blog

Monday, June 23, 2025

From Deportation to K Street: The Curious Liberation of Mahmoud Khalil

 


Judge Michael Farbiarz has gone full-fledged Britney Spears—he did it again.

Another judicial overreach, another breach of the separation of powers—this time sparkling in legalisms, choreographed for political theater, and staged by the progressive legal cartel.

After previously denying Mahmoud Khalil’s release and seemingly acknowledging the Department of Justice landed on solid statutory ground, the judge has now reversed course—again.

This time, in a dizzying turn that flouts immigration procedures, judicial restraint, and common sense, Khalil has not only walked free but also walked out with a golden ticket to lobby Congress.

The reason? Judge Farbiarz now appears to believe the government’s justification may be retaliatory—an attempt to punish Khalil for his political views. “There is at least something to the underlying claim that there is an effort to use the immigration charge here to punish the petitioner,” he said from the bench, calling such a move unconstitutional.

Then, on the heels of a hastily convened telephone hearing, a magistrate judge issued release conditions that included a tailored carve-out: Khalil may travel to Washington, D.C., for “lobbying and legislative activity.”

Let that sink in.

The judiciary, which until now has had no recognized authority under federal law to supervise foreign policy or prescribe non-criminal bond terms for deportable aliens, has now decided it can choreograph congressional visits for someone accused of lying on immigration forms and aligning with a designated terrorist organization.

The Court’s order authorizes Khalil—a non-citizen under a final removal order from an immigration judge—to engage in “lobbying and legislative activity” in Washington, D.C., without requiring any disclosure or oversight.

He is not required, under the terms of the order, to register under the Foreign Agents Registration Act (FARA), a statute that mandates individuals acting on behalf of foreign interests disclose their affiliations and activities to the federal government.

There is no clarity about who he will meet, what legislative business is at stake, or what foreign or domestic interest he may be representing.

“Highly, highly unusual,” Judge Michael Farbiarz said—referring to the government’s justification for detaining Mahmoud Khalil.

But the true aberration is not the administration's case. It’s the contortions of law and logic now emerging under the guise of a habeas action.

Federal immigration law once rested on an iron rule: Article III judges do not substitute their preferences for the findings of immigration courts—let alone override executive branch decisions on the removal of foreign nationals.

There was good reason for this. Congress, which holds the constitutional authority to define judicial jurisdiction, made that boundary explicit in statute. Judge Farbiarz shattered it.

And yet, for all the courtroom speculation about unconstitutional motives, Judge Farbiarz’s written order says none of it. The word unconstitutional is absent. There is no evidentiary finding, no legal standard, not even a passing citation.

Instead, the order states that Khalil’s release is granted “for the reasons stated in court today”—a phrase that does all the heavy lifting of a legal opinion without bearing any of its weight. No reasoning, no record, no responsibility—just a release order conjured in the haze of a hearing and rubber-stamped into effect.

Perhaps, as before, Judge Farbiarz will issue a supplemental order. He did so earlier this month—denying injunctive relief to Khalil in language the administration reasonably interpreted as affirming its statutory authority to proceed with removal. The Department of Justice pivoted accordingly.

That’s the irony: the same evolving court record that opened the door to an alternative legal basis is now being used to challenge that shift as constitutionally suspect.

But when a federal court signals one thing, and the Executive relies on it in good faith—only to be told that its subsequent action may constitute unconstitutional retaliation—that’s not a stable or sustainable approach to the law. It undermines the predictability the rule of law requires and injects uncertainty where constitutional roles should be clear.

Khalil was a legal permanent resident held under 8 U.S.C. § 1227(a)(1)(A) for material misrepresentation on his immigration paperwork. Those charges—related to undeclared affiliations with foreign entities—are statutorily sufficient for removal.

Indeed, the immigration judge in Louisiana reviewed the facts and denied bond and asylum outright on June 20, issuing a formal removal order on the same day.

Rather than defer to the immigration court’s ruling, Judge Farbiarz reasserted his authority.

What’s more, by granting a release condition that permits Mr. Khalil to engage in lobbying activity, the Court has inserted itself into the political sphere—a breach not merely of prudence but of institutional propriety.

In a nutshell, Judge Farbiarz returned to the habeas petition he’d been tinkering with the past several weeks, bypassed the tribunal Congress empowered to adjudicate deportation, and set in motion a release process that culminated in conditions—including a lobbying privilege—conjured from thin air by the magistrate judge.

This is tommyrot on a farcical scale. A federal court is now in the business of approving bespoke legislative visits by a non-citizen under active deportation proceedings.

So much for Mr. Khalil’s stated wish to spend more time with his family.

Instead, he seems intent on advancing a political agenda—one that, judging by the very facts that landed him in legal jeopardy, stands in direct conflict with U.S. foreign policy.

And true to his word, Khalil pledged to resume his pro-Palestinian activism—and was met at the airport by none other than the progressive princess herself, Rep. Alexandria Ocasio-Cortez.

Let the legislative theater and lobbying shenanigans begin.

Getting down to brass tacks: the Court didn’t just question the constitutionality of the Immigration and Nationality Act (INA)—it lent its robe and gavel to undermine it.

By authorizing a foreign national to lobby Congress—almost certainly in ways that conflict with U.S. foreign policy—it inserted itself directly into conduct that the INA identifies as grounds for removal under 8 U.S.C. § 1227(a)(4)(C). Unreal.

But that door swings both ways. There is still an opening for the Department of Justice—and for the Secretary of State. If Mr. Khalil takes the Court’s indulgence as a license to campaign against U.S. foreign policy actively, each such action could constitute fresh statutory grounds for removal.

Under 8 U.S.C. § 1227(a)(4)(C), the government retains the authority to deport a non-citizen who engages in activity that undermines U.S. foreign policy interests.

What the Court has temporarily framed as protected speech—an issue not yet settled by the appellate courts—may yet be grounds for removal if it crosses that statutory line.

If this ruling stands, it invites chaos. Immigration courts are being reduced to sideshows as federal judges become the go-to venues for progressives to extract celebrity detainees—not for justice, but for politics and, inevitably, it seems, fundraising.

The effect is plain: to sideline the political branches—the constitutional voice of the people—in favor of judicial improvisation.

“Highly, highly unusual”?

Justice Robert Jackson said it better. In Harisiades v. Shaughnessy, 342 U.S. 580 (1952), the Supreme Court upheld the government’s authority to deport non-citizens for affiliations hostile to American interests, warning that, 

[A]ny policy toward aliens is vitally and intricately interwoven with contemporaneous policies in regard to the conduct of foreign relations, the war power, and the maintenance of a republican form of government. Such matters are so exclusively entrusted to the political branches of government as to be largely immune from judicial inquiry or interference.

Here’s hoping five justices agree.

Charlton Allen is an attorney and former chief executive officer and chief judicial officer of the North Carolina Industrial Commission. He is founder of the Madison Center for Law & Liberty, Inc., editor of The American Salient, and host of the Modern Federalist podcast. 

https://www.americanthinker.com/articles/2025/06/from_deportation_to_k_street_the_curious_liberation_of_mahmoud_khalil.html

Over 100 women at music festivals in France stabbed with syringes, injected with unknown substances

 


We don’t have to live like this:

At least 145 women across France were targeted in syringe attacks at the Festival of Music 2025 (FĂȘte de la Musique), which offers free concerts in cities across the country.

[snip]

French authorities have not yet indicated what, if any substances, were involved in these specific attacks.

Before I even knew what kind of individuals perpetrated these needle attacks, I already knew—we probably all do—and it wasn’t the few white Frenchmen left but…Muslim migrants. While most of the creeps are still on the lam, a Bangladeshi suspect has been arrested as well as another man who shouted at his victim in Arabic, claiming to be a doctor.

They kept telling us that the waves of third world migrants they were bringing into the West would be tomorrow’s “doctors” and “engineers” so…well-played.

Some of the cities where needle attacks occurred at the highest rates were ChambĂ©ry, Metz, Paris, Montpellier, and Grenoble—and, since many of the women did not experience cognitive issues after being injected, the date-rape drug (GHB), which is typically used, was ruled out. What was in those needles? Semen? HIV?

But the risk of being stabbed with a syringe and injected with an unknown material wasn’t the only violence brought by the migrants during the concerts: there were stabbings, “battles with police,” sexual assault, gang activity, and around 50 cars were lit on fire:



And, here’s a man kicking a young woman on the ground in the head:


While he and his buddies (who fail to intervene) may have French citizenship, they’re certainly not French.

Like I said, we don’t have to live like this—but leftist “progressives” are condemning us to this future—they truly are the biggest blight to ever afflict humanity.

https://www.americanthinker.com/blog/2025/06/more_than_100_women_attending_music_festivals_across_france_stabbed_with_syringes_and_injected_with_unknown_substances.html

Church Massacre Cancelled: Shooter Run Over By Deacon's Truck, Then Fatally Shot By Staff

 What promised to be a ghastly church massacre in Michigan on Sunday was prevented by the speedy reactions of a church deacon and two staff members -- with the deacon unleashing the first blow with his truck before a security guard and another staff member polished off the assailant with gunfire. The drama played out at CrossPointe Community Church in Wayne, Michigan, a western Detroit suburb. Police identified the dead shooter as Brian Anthony Browning, a 31-year-old white male with no known connection to the church.

Browning arrived at the church in Nissan truck shortly after 11 a.m., as a special vacation bible school service was underway, teeming with children and 150 congregants in all. Police say he was wearing a tactical vest and carrying both a handgun and a "long gun" (a pointlessly-vague police term that could describe either a rifle or shotgun). After gaining the attention of staff members by driving recklessly outside the building, Browning exited his vehicle and opened fire on the church. 

Crosspointe Community Church congregants react to the sound of shouting and gunfire close to the church entrance 

That's when he was met with a swift and decisive one-two punch. When a deacon saw the shooter moving toward the church, he immediately turned his Ford F-150 pickup truck into a two-ton weapon, hitting the gas and running Browning over as the fiend fired multiple rounds at him. ["The Ford works in mysterious ways," observes ZeroHedge reader Rattus in an instant-classic comment below.] That bought time for staff members to engage him with gunfire. "At least two staff members shot the gunman, causing fatal wounds," said Wayne Police Chief Ryan Strong. One staffer suffered a gunshot wound to the leg, but is expected to fully recover after undergoing surgery. Though Browning was stopped "quite close" to the church, several of the rounds he fired entered it.  

Live-streamed video of the service captured the congregation's multistage reaction to the attack, which proceeded from distraction to confusion and then fearful retreat, with one of the leaders of the service beckoning everyone to move to the back of the building:

Churchgoer Doug Blair told Fox 2 Detroit that he first mistook the sound of gunfire for construction noises. After hearing someone announce an "active shooter," he ran to a door, propped it open and carefully took a look outside: 

"There was the shooter … on the ground. His weapon, I think he was still firing away, it was on the ground… right before I got to the door, you could hear it was going BAM, BAM, BAM. That's all you heard. When I opened the door, one of our security people was in front of him and one was on the other side of him. They were just both emptying their clips."

Chief Strong praised the swift and effective response. “We are grateful for the quick actions of the church’s staff members, who undoubtedly saved many lives and prevented a large-scale mass shooting,” he said. “I would add that the church parishioners and staff members were trained in responding to emergency situations, which also saved lives.”

The pastor and police say Browning did not appear to have ever been a member of the church, which is located about five miles away from his home in Romulus, Michigan. There's no word yet about a motive. "It appears he was suffering from a mental health crisis," Strong told reporters, an assertion based on interviews already conducted. Police say he had no criminal record, and little biographical information has surfaced thus far, with no reports about his work history. Photos are circulating on social media that purport to show Browning, but there are disputes about their authenticity. 

Chalk up another win for good guys with guns -- and a Ford F-150.  

https://www.zerohedge.com/political/church-massacre-cancelled-shooter-run-over-deacons-truck-then-fatally-shot-staff

Best- & Worst-Run Cities in America (2025)

 The past year has been a true test of the effectiveness of local leadership. City leaders have had to deal with economic difficulties like high inflation, as well as other issues such as mass shootings with over 500 reported in 2024, keeping gun crime in the political spotlight.

Even during less difficult times, running a city is a tall order. The larger the city, the more complex it becomes to manage. In addition to representing the residents, local leaders must balance the public’s diverse interests with the city’s limited resources. That often means not everyone’s needs can or will be met. Leaders must carefully consider which services are most essential, which agencies’ budgets to cut or boost, and whether and how much to raise taxes, among other decisions.

But how do we measure the effectiveness of local leadership? One way is by determining a city’s operating efficiency. In other words, we can learn how well city officials manage and spend public funds by comparing the quality of the services residents receive against the city’s total budget.

Using that approach, WalletHub compared the operating efficiency of 148 of the largest U.S. cities to reveal which among them are managed best. We constructed a “Quality of Services” score made up of 36 metrics grouped into six service categories, which we then measured against the city’s per-capita budget.






Cancer Patients Are Overmedicated To Enrich Health Systems, Study Claims

 by Ge Bai

Are patients being prescribed more medications not for their health, but to generate profit? A new economic study published in The Journal of Health Economics reveals that cancer patients treated by physicians participating in the 340B Program receive more medications—including those outside clinical guidelines—without improvements in survival.

The federal program, named after Section 340B of the Public Health Service Act, was created by Congress in 1992 to support hospitals and clinics serving low-income communities. It allows eligible entities to purchase outpatient drugs at steep discounts and receive full reimbursement, retaining the difference. The Affordable Care Act expanded eligibility criteria, accelerating the program’s growth.

Since 2012, the number of 340B-eligible entities has tripled to more than 60,000. Between 2013 and 2023, discounted drug purchases under the program rose from $8 billion to $66 billion, largely driven by eligible hospitals and their affiliated outpatient facilities. Today, nearly 60% of U.S. pharmacies serve as contract pharmacies, dispensing drugs for 340B-eligible entities. This rapid growth reflects the lucrative “buy-low, sell-high” opportunities created by the program.

Dr. Danea Horn at the University of California, San Francisco, studied the prescribing behavior of physicians treating breast cancer patients before and after their practices began participating in the 340B Program. Her findings are striking: the likelihood of prescribing outpatient drugs per patient increased by over 25%, and the intensity of drug treatment rose by 40%, including medications not aligned with clinical recommendations.

Despite increased medication use, the study found no evidence of improved patient survival—consistent with research indicating that 340B participation does not enhance hospitals’ inpatient care quality. As Dr. Horn concluded, the 340B Program is fundamentally a “cash transfer program” that distorts healthcare markets by inflating drug profit margins, an incentive to which providers actively respond.

Recent research found that 340B-eligible hospitals secured substantial profit margins on outpatient drugs and that the program discouraged biosimilar adoption, favoring expensive brand-name drugs with higher 340B profit margins. Additionally, hospitals strategically manage their patient mix to game the 340B eligibility criteria and expand into wealthier neighborhoods to capture lucrative outpatient drug margins.

In effect, the 340B Program gives eligible entities a substantial financial advantage, creating a deep moat that fends off competitors. Independent physician practices and for-profit hospitals, regardless of their patient mix, are ineligible for the program but must compete with eligible nonprofit hospitals.

This uneven playing field has driven vertical integration, prompting hospitals to acquire physician practices and expand clinics to increase drug revenue. These actions raise commercial prices and worsen the financial burden on patients, directly contradicting the 340B Program’s original intent.

It’s tempting to blame hospital greed for their relentless expansion of 340B-driven operations. However, hospitals—like all other players in healthcare—respond to the incentive structure around them. Why should they be expected to leave easy 340B money on the table? Bad rules ruin the game, often in ways unforeseeable to well-intentioned rulemakers.

Reforming the 340B Program is politically challenging, as it has evolved into an indispensable cash cow for eligible entities, creating entrenched financial and political interests committed to sustaining and expanding it. However, as the public becomes increasingly aware of the nature and implications of this rapidly growing program, a tipping point may emerge for reforms that prioritize and directly empower patients rather than the healthcare entities serving them.

https://www.forbes.com/sites/gebai/2025/06/23/cancer-patients-are-overmedicated-to-enrich-health-systems/

What's So Scary About Medicare Reform?

 One of the biggest questions surrounding Senate Republicans' version of the One Big Beautiful Bill Act concerns the fate of Medicare. Earlier this month, GOP lawmakers were reportedly considering reforms aimed at reducing waste, fraud and abuse in the entitlement as a way to deliver savings for taxpayers.

But as the bill has taken shape in the last few days, Senate Republicans appear to have lost their appetite for tightening the federal purse strings for Medicare.

The conventional wisdom is that any changes to the program would come at too high a political cost for Republicans. But improper payments have been rampant in Medicare for too long.

If Republicans don't take action to eliminate such costly inefficiencies, then taxpayers will continue to watch helplessly as their hard-earned dollars are wasted.

There is no shortage of waste Republicans can target.

Consider how insurers have been abusing Medicare Advantage, the component of the entitlement that allows beneficiaries to purchase federally subsidized private coverage. Over the past few years, insurers have gotten good at gaming the program's rules to extract overpayments from the federal government.

One way they do so is through a strategy known as "upcoding," wherein an insurer goes out of its way to ascribe multiple medical diagnoses to a particular patient. Since MA pays insurers more money for covering higher-risk patients, making a person look sicker than they may actually be is a direct way to increase revenues.

Another technique MA plans employ is "favorable selection" — a process designed to ensure that healthier seniors are overrepresented in MA plans compared to less healthy seniors.

Padding their rolls with healthier patients — and pretending they're sicker than they are — has proven lucrative for insurers. It has also come at a staggering cost to taxpayers.

According to an analysis from the Committee for a Responsible Federal Budget, these two techniques will lead to $1.2 trillion in overpayment to MA plans between 2025 and 2034.

A crackdown on gamesmanship by insurers isn't the only way the GOP can make Medicare more cost-effective. They could also address a glaring inefficiency in how healthcare providers are reimbursed.

At present, Medicare pays about twice as much for routine ambulatory services delivered in a hospital as it does for the same services when delivered in a doctor's office, according to research from the Paragon Health Institute.

That's not just irrational and irresponsible. It incentivizes hospitals to acquire physician practices, change the sign on the door, and start billing Medicare at higher rates. The upshot is a more consolidated, less competitive market for medical care — and higher costs for everyone.

Correcting this payment discrepancy — and transitioning to a "site-neutral" reimbursement framework — could save the federal government as much as $100 billion over the next decade. What's more, it's an approach that garners bipartisan support.

The notion that rooting out waste and abuse in Medicare would inspire a dangerous political backlash for Republicans is mistaken. The GOP needs to find ways to cut federal spending.

Eliminating overpayments to MA plans and ending perverse reimbursement schemes in Medicare are straightforward, commonsense ways to do so.

Sally C. Pipes is President, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. Her latest book is "The World's Medicine Chest: How America Achieved Pharmaceutical Supremacy — and How to Keep It" (Encounter 2025). 

https://www.newsmax.com/sallypipes/medicare-reform/2025/06/20/id/1215805/

TuHURA, Kineta, Inc. Stockholders Approve Proposed Merger and All Related Proposals

 TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced with Kineta, Inc. (OTC Pink:KANT) ("Kineta"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, that TuHURA stockholders approved all of the proposals set forth at the Company's Special Meeting of Stockholders held today, June 23, 2025 (the "TuHURA Special Meeting"). The proposals included an increase of the Company's authorized shares to 200 million shares and a proposal to reincorporate the Company in Delaware.

Additionally, Kineta stockholders approved the proposed merger (the "Merger") with TuHURA at Kineta's Special Meeting of Stockholders held today, June 23, 2025 (the "Kineta Special Meeting"). The parties anticipate that the Merger will close as soon as possible following the satisfaction or waiver of any remaining closing conditions.

The final voting results of the TuHURA Special Meeting and the Kineta Special Meeting will be reported in Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission.

https://finviz.com/news/86367/tuhura-biosciences-inc-and-kineta-inc-stockholders-approve-proposed-merger-and-all-related-proposals